Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 11 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 10975043

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  2. US 10968178

    IP6K inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  3. US 10968231

    Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders

    Takeda Pharmaceutical Company Limited · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  4. US 10968213

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  5. US 10919891

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  6. US 10906898

    Cocrystal

    Takeda Pharmaceutical Company Limited · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  7. US 10898737

    Substituted piperidine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  8. US 10899752

    2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor

    Takeda Pharmaceutical Company Limited · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  9. US 10865200

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted
  10. US 10849902

    Medicament for treating heart failure

    Takeda Pharmaceutical Company Limited · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  11. US 10835541

    Tablet

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  12. US 10836745

    Cocrystal, production method thereof, and medicament containing cocrystal

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  13. US 10807987

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  14. US 10800754

    Heterocyclic amide compound

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  15. US 10786501

    Treatment of prostate cancer

    Takeda Pharmaceutical Company Limited · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  16. US 10787462

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  17. US 10774083

    Heterocyclic amide compound

    Takeda Pharmaceutical Company Limited · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  18. US 10759768

    Prophylactic or therapeutic agent for autism spectrum disorder

    Takeda Pharmaceutical Company Limited · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  19. US 10745397

    1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  20. US 10738004

    Cyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  21. US 10738046

    Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  22. US 10717748

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  23. US 10710989

    Method for producing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  24. US 10696651

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted